Hyperactive Ras in developmental disorders and cancer
By Suzanne Schubbert, K. Shannon, G. Bollag. Nature Reviews. Cancer, 2007
649 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/7e5b0b4ec4b51535dc60cf958b59f5260876ac97
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Germline gain-of-function mutations in SOS1 cause Noonan syndrome (2007, background): “Constitutive activation of this pathway as a result of mutations is considered a key event in the development of several human malignancies and developmental disorder”
- RNA-binding proteins in human genetic disease. (2008, positive): “For example, epidermal growth factor receptor 2 (HER2) gene amplification is frequently observed in breast cancer [64], and activating mutations in the RAS oncogene are highly prevalent in colon cancer [ 65 ].”